Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (834)	8/30/1999 5:04:00 PM
From: wbASSETt	Respond to of 5582

O/T MSGI much less volume today and price dipped slightly. Earning expectation is -$0.18 due out on Thursday (2nd) If there is the slightest positive news, like -$0.17 this one will pop into the 20's But this one is a long term investment, even though the day traders will be playing this along w/ the MM's as it rises back to higher ground wbASSETt

To: Mike M who wrote (834)	8/31/1999 12:18:00 PM
From: Mad2	Respond to of 5582

Mike I don't have any disdain for GUMM (I don't care for Gunn Allen however, but that's another story). Nor have I made any accusations. Furthermore I don't claim that GUMM is going lower near term (I don't know) as I think the potential momentum that Zicam might create makes it a risky short. GUMM is one of 40 or so stocks I follow and one of the few short canidates that I am currently following. I consider it a short canidate as I consider it overvalued according to its revenues, profit and capital, however to me it is just a canidate pending future developments with revenue, profit, capital needs, managment performance and of course Zicam. I post occasionally not to be a jerk but to help present a balanced view. Usually when I'm long or short a stock my posts seldom elaborate on the benifit of the position, rather I stick to presenting factual information which in some cases may support a position I have and other times may not. I personally like to see a contrary viewpoint in stocks I follow as its too easy to become singleminded about a position. Regards, Mad2